CAMCOG data analysis at ZOL: psychometric research

The Ziekenhuis Oost-Limburg (ZOL) is conducting new psychometric research using clinically collected CAMCOG data in patients suspected of neurodegenerative disorders.

Close-up of brain scan or neurological test equipment, with blurred medical charts and data in the background. Soft, clinical lighting. Focus on the technology and data analysis aspect.
AI

Close-up of brain scan or neurological test equipment, with blurred medical charts and data in the background. Soft, clinical lighting. Focus on the technology and data analysis aspect.

The Ziekenhuis Oost-Limburg (ZOL) in Genk is conducting new psychometric research using clinically collected CAMCOG data in patients suspected of neurodegenerative disorders.

For several years, ZOL has been using the CAMCOG as a screening and follow-up instrument for individuals suspected of having a neurodegenerative disorder, such as dementia. The CAMCOG assesses the cognition of older adults, including orientation, language, memory, and attention.
While the psychometric qualities of the instrument have been demonstrated, previous studies are outdated or took place outside Flanders. This study project utilizes clinically collected data to perform new psychometric research.
The research, running from 2021 to 2025, includes various outcomes such as a manuscript by L. Snoeks (2023) and presentations at inspiration days and conferences in 2022 and 2023.
Partners in this project include Mr. Ludwig Snoeks (neuropsychologist at ZOL), Prof. dr. Céline Gillebert, and dr. Hanne Huygelier (both from Brain & Cognition, KU Leuven).
Based on information from the official source: ZOL — Ziekenhuis Oost-Limburg (29/09/2026)